understand but remember that if aezs drops news about a phase 3 trial for cancer cachexia,or a new trial in eu for macrilen for a different indiction like the cancer cachexia,this would be big news,hopefully an asian license deal is not far behind,also aezs 108 was shown to be tremendously effective when used as a combo drug shrinking the tumors by more than 30%,if 1 or some or even all these thing happen on top of getting residuals on the test from the previous licensing deals where in eu we still own all of macrilens patents which is an indication where this going,new trials for macrilen for different uses in eu coming and cancer cachexia phase 3 in usa,what will our pps be then,i think we could hit 5 easily,sell some but keep some on the table as the volumes alone lately along with rise in pps suggests somethings coming,god bless and good luck to all
News 
Market Data 
Discover 
